Atezolizumab and Bevacizumab in Rare Solid Tumors

Conditions:   Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Lip Oral Cavity and Pharynx;   Malignant Neoplasms of Mesothelial and Soft Tissue;   Malignant Neoplasms of Respiratory and Intrathoracic Organs Interventions:   Drug: Atezolizumab;   Drug: Bevacizumab;   Behavioral: Phone Call Sponsors:   M.D. Anderson Cancer Center;   Genentech, Inc. Not yet recruiting - verified March 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials